Cannabinoid-1 receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting N-acylphosphatidylethanolamine-hydrolyzing phospholipase D terminals

Neuroscience

Volumn 227, Issue , 2012, Pages 10-21

  Pickel, V M ^a   Shobin, E T ^a   Lane, D A ^a   Mackie, K ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Aversion; Dynorphin; Electron microscopic immunolabeling; Enkephalin; Reward

Indexed keywords

CANNABINOID 1 RECEPTOR; DYNORPHIN[1-8]; METENKEPHALIN; N ACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D; OPIATE PEPTIDE; PHOSPHOLIPASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; DENDRITE; GLOBUS PALLIDUS; LIMBIC SYSTEM; MALE; MOUSE; NERVE ENDING; NERVE FIBER; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REWARD; SYNAPTIC MEMBRANE;

ANIMALS; DYNORPHINS; ENKEPHALIN, METHIONINE; GLOBUS PALLIDUS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; NEURONS; PEPTIDE FRAGMENTS; PHOSPHOLIPASE D; PRESYNAPTIC TERMINALS; RECEPTOR, CANNABINOID, CB1;

EID: 84867745760     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.07.050     Document Type: Article

References (70)

1. Besson M., Graybiel A., Quinn B. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 1990, 39:33-58.
2. Centonze D., Battista N., Rossi S., Mercuri N.B., Finazzi-Agro A., Bernardi G., Calabresi P., Maccarrone M. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology 2004, 29:1488-1497.
3. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G., Parmentier M., Fratta W. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 2001, 118:61-65.
4. Chan J., Aoki C., Pickel V. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 1990, 33:113-127.
5. De Souza Silva M.A., Jezek K., Weth K., Muller H.W., Huston J.P., Brandao M.L., Hasenohrl R.U. Facilitation of learning and modulation of frontal cortex acetylcholine by ventral pallidal injection of heparin glucosaminoglycan. Neuroscience 2002, 113:529-535.
6. Drake C., Patterson T., Simmons M., Chavkin C., Milner T. Kappa opioid receptor-like immunoreactivity in guinea pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation. J Comp Neurol 1996, 370:377-395.
7. Ellgren M., Artmann A., Tkalych O., Gupta A., Hansen H.S., Hansen S.H., Devi L.A., Hurd Y.L. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence. THC effects. Eur Neuropsychopharmacol 2008, 18:826-834.
8. Fallon J., Leslie F. Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 1986, 249:293-336.
9. Farrar A.M., Font L., Pereira M., Mingote S., Bunce J.G., Chrobak J.J., Salamone J.D. Forebrain circuitry involved in effort-related choice. Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior. Neuroscience 2008, 152:321-330.
10. Frankel P.S., Alburges M.E., Bush L., Hanson G.R., Kish S.J. Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology 2008, 55:41-46.
11. Franklin K., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego.
12. Fu J., Astarita G., Gaetani S., Kim J., Cravatt B.F., Mackie K., Piomelli D. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 2007, 282:1518-1528.
13. Fuller T.A., Russchen F.T., Price J.L. Sources of presumptive glutamergic/aspartergic afferents to the rat ventral striatopallidal region. J Comp Neurol 1987, 258:317-338.
14. Glass M., Dragunow M., Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318.
15. Groenewegen H., Berendse H., Haber S. Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience 1993, 57:113-142.
16. Haller J., Varga B., Ledent C., Freund T. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol 2004, 15:299-304.
17. Harkany T., Hartig W., Berghuis P., Dobszay M., Zilberter Y., Edwards R., Mackie K., Ernfors P. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons. Eur J Neurosci 2003, 18:1979-1992.
18. Hasenohrl R., Souza-Silva M., Nikolaus S., Tomaz C., Brandao M., Schwarting R., Huston J. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 2000, 34:272-280.
19. Hashimotodani Y., Ohno-Shosaku T., Kano M. Endocannabinoids and synaptic function in the CNS. Neuroscientist 2007, 13:127-137.
20. Hohmann A.G., Herkenham M. Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 2000, 37:71-80.
21. Hrabovszky E., Wittmann G., Kallo I., Fuzesi T., Fekete C., Liposits Z. Distribution of type 1 cannabinoid receptor-expressing neurons in the septal-hypothalamic region of the mouse: Colocalization with GABAergic and glutamatergic markers. J Comp Neurol 2012, 520:1005-1020.
22. Hreib K., Rosene D., Moss M. Basal forebrain efferents to the medial dorsal thalamic nucleus in the Rhesus Monkey. J Comp Neurol 1988, 277:365-390.
23. Hubner C.B., Koob G.F. The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res 1990, 508:20-29.
24. Hurd Y.L. Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 1996, 72:767-783.
25. Irving A., Coutts A., Harvey J., Rae M., Mackie K., Bewick G., Pertwee R. Functional expression of cell surface cannabinoid CB 1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience 2000, 98:253-262.
26. Kalivas P., Churchill L., Klitenick M. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 1993, 57:1047-1060.
27. Kalivas P.W., Jackson D., Romanidies A., Wyndham L., Duffy P. Involvement of pallidothalamic circuitry in working memory. Neuroscience 2001, 104:129-136.
28. Katona I., Urban G., Wallace M., Ledent C., Jung K., Piomelli D., Mackie K., Freund T. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 2006, 26:5628-5637.
29. Kessler M.S., Debilly S., Schoppenthau S., Bielser T., Bruns A., Kunnecke B., von Kienlin M., Wettstein J.G., Moreau J.L., Risterucci C. FMRI fingerprint of unconditioned fear-like behavior in rats exposed to trimethylthiazoline. Eur Neuropsychopharmacol 2012, 22:222-230.
30. Kreibich A., Reyes B., Curtis A., Ecke L., Chavkin C., Van Bockstaele E., Valentino R. Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system. J Neurosci 2008, 28:6516-6525.
31. Lane D.A., Chan J., Fitzgerald M.L., Kearn C.S., Mackie K., Pickel V.M. Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D(2) receptors in mouse striatum: relation to cannabinoid-1 (CB (1)) receptor targeting. Psychopharmacology 2012, 221:101-113.
32. Lane D.A., Chan J., Lupica C.R., Pickel V.M. Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of mu-opioid receptors and on dopamine axons in the mouse nucleus accumbens. Synapse 2010, 64:886-897.
33. Leranth C., Pickel V., Heimer L., Zaborszky L. Electron microscopic pre-embedding double immunostaining methods. Neuroanatomical tract-tracing methods 2: recent progress 1989, 129-172. Plenum Publishing Co., New York.
34. Lu X.Y., Ghasemzadeh M.B., Kalivas P.W. Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 1998, 82:767-780.
35. Ma J., Ye N., Lange N., Cohen B. Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus. Neuroscience 2003, 121:991-998.
36. Matyas F., Urban G.M., Watanabe M., Mackie K., Zimmer A., Freund T.F., Katona I. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
37. Miller R., Pickel V. The distribution and functions of the enkephalins. J Histochem Cytochem 1980, 28:903-917.
38. Mitrovic I., Napier T.C. Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum. Eur J Neurosci 2002, 15:257-268.
39. Napier T., Mitrovic I. Opioid modulation of ventral pallidal inputs. Ann NY Acad Sci 1999, 877:176-201.
40. Neal C.R., Newman S.W. Prodynorphin peptide distribution in the forebrain of the Syrian hamster and rat: a comparative study with antisera against dynorphin A, dynorphin B, and the C-terminus of the prodynorphin precursor molecule. J Comp Neurol 1989, 288:353-386.
41. Nickerson P.A., Guerci A., el Mestikawy S., Semba K. Vesicular glutamate transporter 3 immunoreactivity is present in cholinergic basal forebrain neurons projecting to the basolateral amygdala in rat. J Comp Neurol 2006, 498:690-711.
42. Nikolaus S., Huston J., Hasenohrl R. Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P. Neurosci Lett 2000, 283:37-40.
43. Nikoshkov A., Hurd Y.L., Yakovleva T., Bazov I., Marinova Z., Cebers G., Pasikova N., Gharibyan A., Terenius L., Bakalkin G. Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain. FASEB J 2005, 19:1543-1545.
44. Nyilas R., Dudok B., Urban G., Mackie K., Watanabe M., Cravatt B., Freund T., Katona I. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J Neurosci 2008, 28:1058-1063.
45. Pang K., Tepper J.M., Zaborszky L. Morphological and electrophysiological characteristics of noncholinergic basal forebrain neurons. J Comp Neurol 1998, 394:186-204.
46. Parolaro D., Vigano D., Rubino T. Endocannabinoids and drug dependence. Curr Drug Targets CNS Neurol Disord 2005, 4:643-655.
47. Peters A., Palay S., Webster H. The fine structure of the nervous system 1991, Oxford University Press, New York.
48. Pickel V., Chan J., Kearn C., Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 2006, 495:299-313.
49. Riedel A., Hartig W., Seeger G., Gartner U., Brauer K., Arendt T. Principles of rat subcortical forebrain organization: a study using histological techniques and multiple fluorescence labeling. J Chem Neuroanat 2002, 23:75-104.
50. Riegel A.C., Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 2004, 24:11070-11078.
51. Robbe D., Alonso G., Duchamp F., Bockaert J., Manzoni O. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 2001, 21:109-116.
52. Smith J., Co C., Yin X., Sizemore G., Liguori A., Johnson W., Martin T. Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 2004, 27:841-850.
53. Smith K., Berridge K. The ventral pallidum and hedonic reward: neurochemical maps of sucrose "liking" and food intake. J Neurosci 2005, 25:8637-8649.
54. Smith K.S., Berridge K.C., Aldridge J.W. Disentangling pleasure from incentive salience and learning signals in brain reward circuitry. Proc Natl Acad Sci USA 2011, 108:E255-264.
55. Sutt S., Raud S., Areda T., Reimets A., Koks S., Vasar E. Cat odour-induced anxiety-a study of the involvement of the endocannabinoid system. Psychopharmacology 2008, 198:509-520.
56. Svingos A., Colago E., Pickel V. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J Neurosci 1999, 19:1804-1813.
57. Tang X.C., McFarland K., Cagle S., Kalivas P.W. Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum. J Neurosci 2005, 25:4512-4520.
58. Torres-Reveron A., Gray J.D., Melton J.T., Punsoni M., Tabori N.E., Ward M.J., Frys K., Iadecola C., Milner T.A. Early postnatal exposure to methylphenidate alters stress reactivity and increases hippocampal ectopic granule cells in adult rats. Brain Res Bull 2009, 78:175-181.
59. Tsuboi K., Okamoto Y., Ikematsu N., Inoue M., Shimizu Y., Uyama T., Wang J., Deutsch D.G., Burns M.P., Ulloa N.M., Tokumura A., Ueda N. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim Biophys Acta 2011, 1811:565-577.
60. Ueda N., Tsuboi K., Uyama T. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochim Biophys Acta 2010, 1801:1274-1285.
61. Valverde O., Noble F., Beslot F., Dauge V., Fournie-Zaluski M., Roques B. Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci 2001, 13:1816-1824.
62. Van Bockstaele E., Saunders A., Commons K., Liu X., Peoples J. Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus. J Comp Neurol 2000, 417:103-114.
63. Velley L., Milner T., Chan J., Morrison S., Pickel V. Relationship of Met-enkephalin-like immunoreactivity to vagal afferents and motor dendrites in the nucleus of the solitary tract: a light and electron microscopic dual labeling study. Brain Res 1991, 550:298-312.
64. Voorn P. Projections from pallidum to striatum. Handbook of basal ganglia structure and function 2010, 249-255. Academic Press, Amsterdam. H. Steiner, K.Y. Tseng (Eds.).
65. Wager-Miller J., Westenbroek R., Mackie K. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chem Phys Lipids 2002, 121:83-89.
66. Zaborszky L., Cullinan W.E. Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabeling study in rat. Brain Res 1992, 570:92-101.
67. Zahm D.S., Zaborszky L., Alones V.E., Heimer L. Evidence for the coexistence of glutamate decarboxylase and Met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum. Brain Res 1985, 325:317-321.
68. Zhang N., Houser C.R. Ultrastructural localization of dynorphin in the dentate gyrus in human temporal lobe epilepsy: a study of reorganized mossy fiber synapses. J Comp Neurol 1999, 405:472-490.
69. Zhou L., Furuta T., Kaneko T. Chemical organization of projection neurons in the rat accumbens nucleus and olfactory tubercle. Neuroscience 2003, 120:783-798.
70. Zimmer A., Zimmer A., Hohmann A., Herkenham M., Bonner T. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 1999, 96:5780-5785.